Loading...
By Kelly Young
The CDC has provided a list of conditions that should still be treated with doxycycline during the current shortage of the antibiotic that began in January.
Doxycycline is still the treatment of choice for rickettsial infections, such as Rocky Mountain spotted fever, ehrlichiosis, and anaplasmosis. For these infections, treatment delay can be fatal, so having a plan to access doxycycline is vital.
Doxycycline is also recommended for Lyme disease prophylaxis, because no other treatment alternatives have been adequately tested. Still, the CDC says clinicians should be "judicious" in its use for tick bites. The antibiotic should also continue to be used for malaria prophylaxis and treatment.
For treatment of sexually transmitted infections and Lyme disease, other antibiotics may be more appropriate during the shortage.
Some forms of doxycycline hyclate and doxycycline monohydrate are still in short supply, but the FDA is not reporting a shortage of intravenous doxycycline hyclate or the oral suspension doxycycline calcium.
Comment
LINK(S):
CDC health advisory (Free)
FDA's doxycycline shortage listing (Free)